Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In SURMOUNT1, up to 20.9% body weight reduction at 72 weeks (15 mg dose)
Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering
Benefits leaders can instead focus on finding clinically appropriate ways of supporting the right individuals
The maintenance pill The ATTAIN-MAINTAIN trial involved participants from the companys earlier SURMOUNT-5 study, which directly compared semaglutide and tirzepatide
Originally developed for the treatment of type 2 diabetes, these peptide-based drugs are now at the forefront of both metabolic disease management and obesity treatment, driving unprecedented market growth and industry attention
US$ 24.55
US$ 28.20
US$ 25.34
US$ 29.44
US$ 20.48
US$ 27.59
![메디칼타임즈] 대세인 GLP-1 비만약…국내사 차별화 공략 가능할까](https://pdscdn.medicaltimes.com/Thumnail/20231106/1699238980.jpg)
US$ 22.55
US$ 28.52
